Completion of the infusion conversion procedure of “Biopharm Engineering” AD

Sofia, Bulgaria, August 23, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that the transformation by merger of "Biopharm Engineering" AD into "Sopharma" AD has been entered in the Commercial Register with number 20230823133229 with which "Biopharm Engineering" AD was deleted without liquidation. The activity of "Biopharm Engineering" AD is completely transferred to "Sopharma" AD, and all the assets of the merging company are transferred to "Sopharma" AD, which becomes its universal legal successor.